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Abstract
Sex chromosomes originated from autosomes but have evolved a highly specialized chromatin structure. Drosophila Y
chromosomes are composed entirely of silent heterochromatin, while male X chromosomes have highly accessible
chromatin and are hypertranscribed as a result of dosage compensation. Here, we dissect the molecular mechanisms and
functional pressures driving heterochromatin formation and dosage compensation of the recently formed neo-sex
chromosomes of Drosophila miranda. We show that the onset of heterochromatin formation on the neo-Y is triggered by an
accumulation of repetitive DNA. The neo-X has evolved partial dosage compensation and we find that diverse mutational
paths have been utilized to establish several dozen novel binding consensus motifs for the dosage compensation complex
on the neo-X, including simple point mutations at pre-binding sites, insertion and deletion mutations, microsatellite
expansions, or tandem amplification of weak binding sites. Spreading of these silencing or activating chromatin
modifications to adjacent regions results in massive mis-expression of neo-sex linked genes, and little correspondence
between functionality of genes and their silencing on the neo-Y or dosage compensation on the neo-X. Intriguingly, the
genomic regions being targeted by the dosage compensation complex on the neo-X and those becoming heterochromatic
on the neo-Y show little overlap, possibly reflecting different propensities along the ancestral chromosome that formed the
sex chromosome to adopt active or repressive chromatin configurations. Our findings have broad implications for current
models of sex chromosome evolution, and demonstrate how mechanistic constraints can limit evolutionary adaptations.
Our study also highlights how evolution can follow predictable genetic trajectories, by repeatedly acquiring the same 21-bp
consensus motif for recruitment of the dosage compensation complex, yet utilizing a diverse array of random mutational
changes to attain the same phenotypic outcome.
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Introduction
Sex chromosomes evolve from ordinary autosomes [1].
Degeneration of the Y chromosome is a general facet of sex
chromosome evolution, and old Y chromosomes are gene poor,
often contain high amounts of repetitive DNA, and in Drosophila
the Y is entirely heterochromatic [2]. The euchromatic, gene-rich
X, in contrast, has adopted a hyperactive chromatin configuration,
resulting in hyper-transcription of X-linked genes in male
Drosophila (i.e., dosage compensation). While ultimately resulting
in opposite phenotypic outcomes, the formation of hyperactive
chromatin on the X and silent heterochromatin on the Y has
intriguing parallels [3,4]. Both are initiated at specific nucleation
sites, are associated with characteristic histone modifications, and
spreading of the modified chromatin configuration across tens of
kilobases allows genomic neighborhoods to adopt a similar silent
or hyperactive chromatin state.
In particular, dosage compensation in Drosophila occurs by
doubling the transcription rate of X-linked genes in males [5],
through recruitment of the MSL-complex to specific chromatin
entry sites (CES) on the X in a sequence-specific manner [6,7].
The MSL-complex in D. melanogaster targets a 21-bp GA-rich DNA
sequence motif found at most CES, termed the MSL recognition
element (MRE) [6,7], and roughly 150 CES have been identified
on the X chromosome of D. melanogaster [6,7]. Co-transcriptional
targeting and spreading of the MSL-complex along the X
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chromosome results in MSL-binding of most active genes and
their transcriptional upregulation, mediated by changes in the
chromatin structure of the X (through histone H4 lysine 16
acetylation [H4K16ac] [8–10]). Less is known about how a
genomic region is targeted to adopt a heterochromatic configu-
ration, but repetitive elements are thought to be involved in
triggering the initiation and spreading of silencing heterochroma-
tin [11,12]. Several studies, particularly in yeast, have suggested
that RNAi-mediated silencing pathways can initiate the formation
of heterochromatin (reviewed in [13–15]). Transcripts from
repetitive elements in the centromeric region of fission yeast are
processed into small interfering siRNAs and incorporated into an
RNAi-induced transcriptional silencing complex that recognizes
and binds homologous regions to initiate gene silencing via histone
H3 lysine 9 methylation (H3K9me2/3) [16,17]. Drosophila
centromeres also contain actively transcribed satellite- and
transposon-fragment repeats [18,19], and mutations in genes
encoding the RNAi pathway disrupt HP1 localization and
heterochromatin formation. This suggests that a similar mecha-
nism for RNAi-mediated heterochromatin assembly operates in
Drosophila as well, and recent work has shown how transposons
and the piRNA pathway affect chromatin patterns in Drosophila
[20–22].
How epigenetic modifications are acquired on sex chromo-
somes is a puzzle, and little is known about how dosage
compensation and heterochromatin formation evolve on a
newly formed sex chromosome pair. That is, how are new
nucleation sites to trigger dosage compensation or heterochro-
matin formation acquired on a former autosome, how does a
genomic region become targeted to adopt a hypertranscribed or
heterochromatic appearance, what functional pressures drive
the evolution of dosage compensation and heterochromatin
formation, and how do they interact?
In D. miranda, a new sex chromosome formed about 1 million
years (MY) ago, through a fusion of an autosome with the
ancestral Y chromosome (Figure 1A) [23]. These ‘‘neo-sex’’
chromosomes are at an intermediate stage in the transition from a
pair of autosomes to a pair of heteromorphic sex chromosomes. In
particular, the neo-Y of D. miranda is undergoing massive
degeneration: it is rapidly accumulating repetitive DNA, is
evolving a heterochromatic appearance, and about 40% of its
ancestral genes have become non-functional (i.e., they have
acquired frame shift mutations or stop codons on the neo-Y, or
have been completely lost, [24–27]). Gene expression is
generally reduced at neo-Y genes compared to their neo-X
homologs [25,28], but its chromatin structure, and the
association of heterochromatin and gene expression, has not
yet been studied at the molecular level. The neo-X, in contrast,
is beginning to acquire partial dosage compensation by
coopting the MSL machinery that has evolved to compensate
the ancestral X chromosome that is shared among all
Drosophila species (Figure 1B–1D) [29–31]. MSL-mediated
dosage compensation is found throughout the Drosophila genus
[29–31], and several components of the dosage compensation
complex have male-specific gene expression patterns and target
the newly formed X chromosomes of D. miranda males (Figure
S1) [29,30]. The characteristic histone modification induced by
the MSL-complex (H4K16ac) is also enriched at all the male X
chromosomes of D. miranda, including the neo-X [30,31],
supporting that the function of MSL is conserved across the
Drosophila genus. We have previously studied MSL-binding
patterns in D. miranda using ChIP-seq, in order to identify
genes on the X chromosomes that are targeted by the dosage
compensation complex, and we have shown that the sequence
motif and function of CES is conserved between D. miranda and
D. melanogaster [32]. ChIP-seq profiling of MSL3 identified 68
novel CES that have already evolved on the neo-X of D.
miranda, and, via spreading of the MSL-complex, about 607
neo-X genes (22% of all annotated genes on the neo-X) are
MSL-bound (and 37% of actively transcribed genes) [32].
Binding of the MSL-complex may be more transient for some
genes [33], and about 1,203 genes on the neo-X are bound by
MSL and/or enriched for H4K16ac, the histone mark
deposited by the MSL-complex (i.e., 44% of all genes, and
73% of actively transcribed genes may already be dosage
compensated on the neo-X; [32]). The mutational paths that
create novel CES on the neo-X, and the dynamic interactions
of evolving dosage compensation on the neo-X versus
degeneration of the neo-Y, however, have not been systemat-
ically investigated. Here, we examine the acquisition of dosage
compensation on the neo-X chromosome and formation of
heterochromatin on the neo-Y of D. miranda at the molecular
and functional level, in order to identify how epigenetic
modifications evolve on nascent sex chromosomes.
Author Summary
Sex chromosomes differ from non-sex chromosomes
(‘‘autosomes’’) at the genomic, transcriptomic, and epige-
nomic level, yet the X and Y share a common evolutionary
origin. The Drosophila Y chromosome is gene-poor and
associated with a compact and transcriptionally inactive
form of genetic material called heterochromatin. The X, in
contrast, is enriched for activating chromatin marks and is
consequently hyper-transcribed, a process thought to be
an adaptation to decay and silencing of genes on the Y,
resulting in ‘‘dosage compensation.’’ How sex chromo-
somes have altered their chromatin structure, and what
genomic changes led to this dramatically different epige-
netic makeup, however, has remained a mystery. By
studying the genome, epigenome, and transcriptome of
a species with a very recently evolved pair of sex
chromosomes (the neo-X and neo-Y of a fruit fly,
Drosophila miranda), we here recapitulate how both
dosage compensation and heterochromatin formation
evolve in Drosophila and establish several novel and
important principles governing the evolution of chromatin
structure. We dissect the evolutionary history of over 60
novel binding sites for the dosage compensation complex
that evolved by natural selection on the neo-X within the
last one million years. We show that the 21-bp consensus
motifs for recruiting the dosage compensation complex
were acquired by diverse molecular mechanisms along the
neo-X, while the onset of heterochromatin formation is
triggered by the accumulation of transposable elements,
leading to silencing of adjacent neo-Y genes. We find that
spreading of these chromatin modifications results in
massive mis-expression of neo-sex linked genes, and that
little correspondence exists between functional activity of
genes on the neo-Y and whether they are dosage-
compensated on the neo-X. Intriguingly, the genomic
regions being targeted by the dosage compensation
complex on the neo-X and those that are heterochromatic
on the neo-Y show little overlap, possibly reflecting
different propensities of the ancestral chromosome that
formed the sex chromosome to evolve active versus
repressive chromatin configurations. These findings have
broad implications for current models of sex chromosome
evolution.
Evolving Epigenetic Landscape of Sex Chromosomes
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Results
Acquisition of MSL-Binding Sites on the Neo-X
Previous work has shown that parts of the neo-X of D. miranda
have acquired MSL-mediated dosage compensation [29–32];
however, the evolutionary processes involved in the formation of
the CES on this chromosome remain unknown. Evolving novel
CES along a new X chromosome to initiate dosage compensation
presents a challenge. To recruit the MSL complex, a 21-bp GA-
rich DNA segment (MRE, see Figure 2A) [6,7], needs to be
acquired on many locations along the newly formed X. Multiple
mutations may be necessary to evolve that sequence motif at a
particular genomic location and the emergence of a novel binding
site may require the presence of a pre-site on the neo-X (i.e., a site
that shows high sequence similarity to a MRE). While our previous
study provided evidence that a CES can be created by tandem
amplification of a short GA-rich sequence [32], that work focused
on a single CES and it remains unclear whether the other 67 CES
evolved via similar mechanisms. The neo-X chromosome of D.
miranda segregates as an autosome in its closely related sister
species D. pseudoobscura and D. affinis, and comparative sequence
analysis allows us to reconstruct, to some extent, the path evolution
has taken to acquire the MSL-binding motifs on the neo-X. In
particular, we aimed to identify mutational events within the 68
putative CES on the neo-X that were unique to D. miranda and
would create a novel or stronger MRE on the neo-X (Figure 2B).
We excluded two CES regions that we were not able to align to D.
affinis. In 25 cases, we were not able to identify the mutations that
created a putative CES on the neo-X (see Figure 2B). For the
remaining 41 CES, we found several different mutational routes to
evolve novel MREs on the neo-X (see Figure 2C for representative
examples). At 28 CES, insertion or deletion mutations created a
novel CES on the neo-X at a genomic region that has little or no
affinity for the MSL complex in outgroup species. In seven cases,
simple nucleotide mutations have generated a stronger recruit-
ment motif for the MSL-complex on the neo-X at a pre-site, and
in four cases, a GA-microsatellite expansion created a stronger
MRE motif at a pre-site. Another mechanism to generate new
CES, found twice, involves the modification and tandem
amplification of a pre-binding site for the MSL-complex on the
neo-X (five and nine tandem copies, respectively). This may
increase the affinity of the MSL-complex for such a genomic
location and create a more efficient CES. Indeed, we find that
CES containing multiple non-overlapping MREs are more
strongly bound by the MSL-complex compared to those with a
single MRE present (p=0.038 one-tailed Wilcoxon test; Figure
S2). Thus, a broad spectrum of mutational events has contributed
to the evolution of novel CES on the neo-X. Only half of the CES
identified on the neo-X required the presence of a pre-site,
suggesting that the acquisition of dosage compensation is not
necessarily constrained by the fortuitous presence of a sequence
that resembles the MSL-recognition motif.
Figure 1. Dosage compensation of the neo-X, and heterochromatin formation on the neo-Y of D. miranda. (A) Schematic karyotype of D.
miranda. Drosophila chromosomes are labeled as ‘‘Muller element’’ from A to F. In D. miranda, two fusions between element A (ancient X) and D, and
the Y chromosome and element C created sex chromosomes of different ages. Element D became chrXR about ,10–15 MY ago and element C
became the neo-X and neo-Y chromosome about ,1–1.5 MY ago. (B–C) Polytene chromosomes stained for H3K9me2 (green) and HP1a (red) in (B)
female D. miranda and (C) male D. miranda. (D) Co-immunolocalization of MSL3-TAP (red) and H3K9me2 (green) in transgenic male D. miranda
expressing TAP-tagged MSL3. The neo-Y is becoming heterochromatic, as shown by prominent H3K9me2 and HP1 binding, while all three X-
chromosome arms are acquiring dosage compensation in D. miranda males.
doi:10.1371/journal.pbio.1001711.g001
Evolving Epigenetic Landscape of Sex Chromosomes
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Heterochromatin Formation on the Neo-Y and Repetitive
Elements
The neo-Y, in contrast, is beginning to evolve a heterochro-
matic appearance [26,27]. Immunostaining of polytene chromo-
somes demonstrates that the neo-Y is highly enriched for histone
modification H3K9me2 (a modification characteristic of hetero-
chromatin) and bound by HP1a (heterochromatin protein,
recognizing H3K9me2), relative to the neo-X or the rest of the
genome (Figure 1). We obtained ChIP-seq profiles of H3K9me2 to
confirm enrichment of this repressive histone mark on the neo-Y
and identify sequence features that are associated with hetero-
chromatin formation. Analyses of the neo-Y genomic sequence is
complicated by two characteristics of the neo-Y [24,25,27,34]: On
one hand, the neo-Y is highly repetitive, resulting in a fragmented
de novo genome assembly; on the other hand, unique sequences on
the neo-Y are rather similar to their neo-X homologs, and not all
sequencing read-pairs can be mapped unambiguously to either the
neo-X or neo-Y. We thus identified diagnostic SNPs between the
neo-X and neo-Y chromosome based on comparisons of male and
female genomic libraries, which were used to determine relative
enrichment of H3K9me2 at neo-Y versus neo-X gene regions (see
Methods for more details). Indeed, we find that the repressive
histone mark H3K9me2 is highly enriched at neo-Y genes relative
to their neo-X homologs (Figure 3A and 3B), consistent with the
polytene chromosome immunostaining results. The initiation of
heterochromatin at a specific genomic region and subsequent
spreading is less well understood in Drosophila, but is thought to
be triggered by the presence of repetitive DNA [11,12]. The neo-Y
of D. miranda shows a striking enrichment of transposable elements,
with about 30%–50% of its DNA being derived from repeats [24–
27], and the genome assembly of the neo-Y is highly fragmented
due to its high repeat content [25]. To assay if transposable
elements contribute to heterochromatin formation on the neo-Y,
we measured local repeat density around focal genes and their up/
down stream regions on the neo-Y relative to the neo-X, by taking
advantage of mate-pair relationships of genomic libraries from
male D. miranda. In particular, we anchored the genomic reads to
neo-X/neo-Y diagnostic SNPs, and assayed which fraction of
mate-pair reads would map to a repeat library generated for D.
miranda (see Materials for details). Indeed, we found that neo-Y
genes in regions of higher repeat density show elevated H3K9me2
binding levels (Figure 3C, linear correlation p-value= 0.000308).
Thus, our data support current models of heterochromatin
formation with repetitive elements enabling initiation or spreading
of heterochromatin along the neo-Y.
Interaction of Dosage Compensation, Neo-Y Gene Decay,
and Heterochromatin Formation
Dosage compensation is thought to evolve in direct response to
Y degeneration [35]. Heterochromatin formation, on the other
hand, could either be an adaptation to silence maladaptive genes
on the neo-Y or genes whose homologs are dosage compensated
on the neo-X [36], or it could have deleterious consequences if
silencing arises at potentially functional genes [37]. If gene decay
on the Y chromosome is driving the evolution of dosage
compensation [35,38], neo-X genes with a nonfunctional neo-Y
copy should be preferentially bound by the dosage compensation
complex. However, spreading of the MSL-complex also implies
Figure 2. Acquisition of CES on the D. miranda neo-X chromosome. (A) MRE identified in D. miranda [32]. (B) Number of occurrences of the
different mutational events identified to create a MRE on the neo-X. The ‘‘Undecipherable’’ category refers to CES where no MRE was detected on the
neo-X (‘‘No motif hit’’; 6 CES), or where D. miranda had an equally scoring (‘‘Presite’’; 12 CES) or lower scoring motif than the outgroup species
(‘‘Lower scoring motif’’; 7 CES). This suggests that some of the CES may be false positives (i.e., they are highly bound by the MSL-complex through
spreading rather than through MRE-mediated targeting) or that secondary mutations in adjacent regions occurred to enable efficient recruitment of
the MSL complex to suboptimal MREs on the neo-X. (C) Examples of different mutational events identified on the neo-X to create a novel MRE.
Multiple species alignments are shown for dmir, D. miranda; dpse, D. pseudoobscura; daff, D. affinis; and the MRE element is highlighted in grey.
doi:10.1371/journal.pbio.1001711.g002
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that neo-X genes with functional neo-Y homologs can become
dosage compensated if they reside close to a CES. We divide genes
on the neo-Y into non-functional genes if they contain frame-shift
mutations or premature stop codons, or if they are deleted from
the neo-Y and potentially functional genes if they have an intact
open reading frame. Note that the potentially functional genes
might nevertheless contain amino-acid substitutions that render
them non-functional, or they may contain disabling mutations in
their regulatory regions and may not be expressed on the neo-Y.
In total, 22% of all annotated neo-sex genes are bound by the
MSL-complex on the neo-X (Figure S3). However, MSL-binding
in D. melanogaster is more transient than its more broadly
distributed chromatin mark H4K16ac [33], and we see a similar
pattern in D. miranda (Figure S4; Table S1); 44% of all genes on the
neo-X are dosage compensated, if compensation is defined by
either MSL- and/or H4K16ac enrichment (Figure 4A). We find
MSL complex binding/H4K16ac enrichment at 46% of the neo-
X homologs of neo-Y genes with disrupted ORFs. This value is
similar to MSL and/or H4K16ac binding to neo-X genes with
intact neo-Y homologs (44% bound on the neo-X; Fisher exact test
p-value = 0.28; see Figure 4A). Further, of neo-X genes whose neo-
Y homologs are transcriptionally silent (fragments per kilobase of
transcript per million mapped reads [FPKM],1, see Methods),
only 37% are bound by the MSL-complex/enriched for
H4K16ac, significantly fewer than neo-X genes with a transcribed
neo-Y copy (51%, Fisher exact test p-value= 1.6e–12; Figure 4A).
Thus, a large number of genes have become dosage compensated
on the neo-X, regardless of whether their neo-Y homolog is
functional or not. Moreover, the homologs of genes that are
actively transcribed on the neo-Y actually appear more likely to be
targeted by the dosage compensation complex on the neo-X,
which is contrary to the expectation that dosage compensation has
evolved to counterbalance reduced expression of genes that have
become silenced on the neo-Y. These patterns of MSL binding are
probably due to spreading of the MSL complex in cis from CES
(see also below). In particular, the recruitment of the MSL-
complex to the neo-X by only 68 CES causes dosage compen-
sation of over 1,200 transcribed genes. Hence, the acquisition of
each CES could have been driven by only a few dosage-sensitive
genes on the neo-X (with a nonfunctional neo-Y copy), and most
other neo-X genes within each compensated block might have
acquired dosage compensation unnecessarily through spreading of
the MSL complex. Consistent with spreading passively compen-
sating many neo-X genes, gene ontology (GO) enrichment analysis
reveals no clear categories of genes as being targeted by the MSL-
complex or not (Table S2). On the other hand, non-functional
genes on the neo-Y (those with disrupted ORFs) are more likely to
be associated with H3K9me2 (Fisher exact test, p,0.01;
Figure 4B). This is consistent with the idea that heterochromatin
formation might allow silencing of maladaptive neo-Y genes [36],
or silenced genes are free to accumulate nonsense mutations
neutrally [37]. However, this association is far from perfect, and
many genes with disrupted ORFs (46%) are not silenced by
H3K9me2, and many genes with intact ORFs (47%) are targeted
by heterochromatin (see Figure 4B).
Gene Expression on the Evolving Sex Chromosomes
Partial degeneration and silencing of neo-Y genes, and
incomplete dosage compensation of the neo-X suggest that there
may be massive misexpression of neo-sex linked genes in male D.
miranda. Many genes that are non-functional or silenced on the
neo-Y are not yet dosage compensated on the neo-X, while
homologs of functional neo-Y genes often reside within dosage
compensated blocks on the neo-X. To confirm that MSL binding
or enrichment for chromatin marks which are associated with
dosage compensation (H4K16ac) result in transcriptional upregu-
lation of neo-X linked genes in D. miranda, we compared
expression patterns for neo-X genes between males and females
Figure 3. Heterochromatin formation on the neo-Y of D. miranda. (A) Enrichment profile of H3K9me2 on the D. miranda neo-sex
chromosomes. Intensity ratios are plotted for H3K9me2 (y-axis) relative to chromosomal position (x-axis), for protein-coding genes and their flanking
regions along the neo-sex chromosomes. (B) Genome Browser screen capture of a 50 kb region on the neo-sex chromosomes showing intensity
ratios for histone marks (H3K9me2, in black) and read coverage depth for RNA-seq data (in red) for the neo-Y and neo-X chromosomes in male third
instar larvae. Gene models for potentially functional neo-Y genes are in blue, and for non-functional neo-Y genes in black. (C) TE accumulation on the
neo-Y relative to the neo-X, versus H3K9me2 binding along the neo-Y. The ratios of neo-Y repeat-linked read numbers versus neo-X repeat-linked
reads were pooled into four bins of equal size, as a reflection of the degree of neo-Y specific repeat accumulation. The boxplots show the neo-Y
specific H3K9me2 binding ratios within each bin, and genes without neo-Y specific repeat enrichments show a significantly lower H3K9me2 binding
(Wilcoxon one tailed test: p-value,0.05) than others. The number of asterisks reflects the significance level. *, p-value,0.05; **, p-value,0.01; ***, p-
value,0.0001.
doi:10.1371/journal.pbio.1001711.g003
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in D. miranda to their ‘‘ancestral’’ sex-biased expression in D.
pseudoobscura, where they are autosomal (Figure 4C, panel 1). Our
genome assembly of the repeat-rich neo-Y is not yet of sufficient
quality and contiguity to directly extract genes; instead, we used de
novo assemblies of the transcriptome to compare transcript
abundance between neo-X and neo-Y homologs, and between
sexes and species (see Methods). Conditioning on active transcrip-
tion (based on H3K36me3 enrichment, a chromatin marker
associated with transcribed regions), we find that neo-X genes that
are bound by MSL/H4K16ac (or only MSL; Figure S5) are
upregulated, on average, relative to genes that are not associated
with those marks (Figure 4C, panel 2). Importantly, however, neo-
X genes that lack dosage compensation are not simply transcribed
at half the level of genes bound by MSL/H4K16ac (see Figure 4C,
panel 2). Instead, buffering mechanisms for expression of haploid
genes, as generally observed in Drosophila [39,40], result in partial
compensation of genes that are not targeted by the dosage
compensation machinery. Further, many genes are still transcribed
from the neo-Y, despite being dosage compensated on the neo-X,
or despite harboring frame-shift mutations and stop codons
(Figure 4C, panel 3, and 4D), and there is no statistical association
between MSL-binding levels of neo-X genes and downregulation
of their neo-Y homologs (F-statistic test p-value = 0.73; Figure S6).
In fact, if expression from the neo-Y chromosome is taken into
account, many genes appear over-expressed in male D. miranda
(Figure 4C, panel 4). However, it is unclear if the neo-Y copies,
which often contain several amino-acid or nonsense mutations
[24,25], can functionally substitute for their neo-X homologs.
Genes are generally transcribed at a much lower level from the
neo-Y relative to the neo-X (Figure 4C, panel 3, and 4D) [25,28],
which could in part be caused by changes to its chromatin
structure. Consistent with H3K9me2-induced silencing, we find
Figure 4. Dosage compensation and gene silencing. Genes that are targeted by the MSL complex or enriched for H4K16ac on the neo-X are
shown in pink, and genes that are neither bound by MSL nor H4K16ac are shown in grey. (A) The proportion of MSL-bound/H4K16ac enriched genes
does not differ between neo-X genes whose neo-Y homologs are potentially functional (intact neo-Y ORF) versus those whose neo-Y homologs are
non-functional (disrupted neo-Y ORF). Genes that are transcriptionally silent on the neo-Y (silent neo-Y, FPKM,1) are less likely to be dosage
compensated on the neo-X, while actively transcribed neo-Y genes (active neo-Y, FPKM.1) are more often dosage compensated. (B) Pseudogenes on
the neo-Y (disrupted neo-Y ORF) are significantly more likely to be targeted by H3K9me2 than potentially functional neo-Y genes (Fisher exact test,
p,0.01). (C) Upregulation of gene expression by the dosage compensation complex on the neo-X. Shown is the expression of Muller C genes in
males versus females (M/F), and genes are divided into those bound by the MSL complex and/or H4K16ac-marked on the neo-X in D. miranda (pink)
versus those not targeted by the dosage compensation machinery on the neo-X (grey). Only transcripts with FPKM.2 are included. D. pse (panel 1):
M/F expression of Muller C genes in D. pseudoobscura. D. mir neo-X (panel 2): Expression of the neo-X allele in males versus females. M/F expression is
significantly higher for genes targeted by the dosage compensation complex compared to neo-X genes that are not targeted (Wilcoxon test:
W= 64,915, p,1024), whereas the M/F ratio in D. pseudoobscura is indistinguishable between homologs of bound and unbound genes (Wilcoxon
test: W=51,929, NS). Haploid output of dosage compensated neo-X genes is slightly higher than diploid expression of D. pseudoobscura homologs
(Wilcoxon test: W=149,307, p,0.01) (panels 1 and 2) whereas haploid output of unbound neo-X genes is not increased to the same extent, i.e., it is
significantly lower compared to diploid expression in D. pseudoobscura (Wilcoxon test: W=18,272, p,0.05) (panels 1 and 2). D. mir neo-Y (panel 3):
Expression of the neo-Y allele in males versus the neo-X in females. Neo-Y expression is significantly reduced compared to neo-X expression (MSL/
H4K16ac genes: Wilcoxon test: W=17,481, p,10215; genes not targeted by MSL/H4K16ac: Wilcoxon test: W=3,006, p,10215) (panels 2 and 3). D. mir
neo-X and neo-Y (panel 4): Adding up the FPKM-values of neo-X and neo-Y linked genes leads to an estimate of the overall output from the neo-sex
chromosomes. Combined neo-sex expression is significantly higher than autosomal expression of homologs in D. pseudoobscura (MSL/H4K16ac
genes: Wilcoxon test: W= 123,412, p-value,10215; genes not targeted by MSL/H4K16ac: Wilcoxon test: W=17,455, p,1025) (panels 1 and 4). (D) As
in (C), neo-Y genes whose homologs are dosage compensated on the neo-X are shown in pink, and neo-Y genes with un-compensated neo-X
homologs are shown in grey. Neo-Y/neo-X transcript levels are indistinguishable comparing genes with intact neo-Y ORF versus disrupted neo-Y ORF
(Wilcoxon test: W= 13,588, NS, and W=7,096, NS), suggesting that downregulation of the neo-Y occurs independently of dosage compensation on
the neo-X. However, absolute expression of non-functional neo-Y genes is lower compared to that of functional neo-Y genes (Wilcoxon test:
W= 52,980, p,1024). (E) H3K9me2-bound neo-Y genes (shown in green) are expressed at significantly lower levels than genes not targeted by
H3K9me2 on the neo-Y (shown in grey) (Wilcoxon test: W= 57,006; p,10215 [functional genes] and W=20,662; p,10215 [pseudogenes]; all FPKM-
values are included). (F) Downregulation of neo-Y genes that are targeted by H3K9me2. Potentially functional neo-Y genes are shown in black,
pseudogenes in grey; the vertical line indicates the cut-off value for H3K9me2-bound versus unbound genes.
doi:10.1371/journal.pbio.1001711.g004
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lower expression of H3K9me2 bound neo-Y genes (Figure 4E) and
a significantly negative correlation between H3K9me2-binding
versus transcript levels for neo-Y genes (p-value,2.2e–16,
coefficient =21.26; Figure 4F).
Chromatin Structure Evolution
If epigenetic silencing on the neo-Y evolves in direct response to
dosage compensation of neo-X genes, or vice versa, we would expect
to find the homologs of compensated genes on the neo-X being
preferentially targeted by H3K9me2 on the neo-Y. Contrary to
this expectation, we detect an overall negative correlation between
levels of H4K16ac (or MSL)-binding of neo-X linked loci, and
H3K9me2 binding of neo-Y genes (p-value = 6.2161026, linear
regression coefficient =20.08; Figure 5A and 5B), and the pattern
is more prominent in neo-Y genes bound by H3K9me2
(p-value = 4.5861029, coefficient =20.15). This means that dos-
age compensated neo-X regions are somewhat less likely to have
been silenced by heterochromatin on the neo-Y. This negative
relationship may in fact reflect different propensities of the
ancestral chromosome that formed the neo-sex chromosome to
adapt ‘‘active’’ versus ‘‘repressive’’ chromatin configurations. In
particular, spreading of the MSL-complex is targeted to actively
transcribed regions [41], while heterochromatin is more prone to
form in silent, non-transcribed DNA [42]. An ideal outgroup to
establish the ancestral chromatin structure of the neo-sex
chromosomes would be D. pseudoobscura, where this chromosome
is still an autosome. In the absence of such data, we used D.
melanogaster chromatin data and chromatin profiles from D. miranda
females as a proxy for the ancestral chromatin structure of the neo-
sex chromosomes. If we classify D. miranda genes according to their
principal chromatin types in D. melanogaster [43], we observe a
general agreement between expression patterns in D. miranda and
chromatin type (i.e., reduced gene expression in repressive
chromatin, and higher gene expression in active chromatin;
***
**
Figure 5. Heterochromatin formation and dosage compensation. (A) Sliding window enrichment profile of H3K9me2-enrichment along neo-
Y genes, and H4K16ac and MSL-binding along their neo-X homologs. (B) H4K16ac-enrichment of neo-X genes versus H3K9me2-enrichment at their
neo-Y homologs. Genes are color coded according to their chromatin state in D. melanogaster [43], with yellow and red corresponding to genes
located in active chromatin, and black, green, and blue corresponding to genes located in repressive chromatin. (C) MSL/H4K16ac-bound/unbound
neo-X genes and H3K9me2-bound/unbound neo-Y genes versus principle chromatin types in D. melanogaster. The color-coded chromatin types of D.
miranda bound/unbound genes were inferred from the chromatin type definition of their D. melanogaster orthologs (from [43]). Genes within
‘‘yellow’’ chromatin are more likely to be targeted by the dosage compensation complex on the neo-X. Genes within ‘‘black’’ chromatin are more
likely to be silenced by H3K9me2 on the neo-Y. Genes within active ‘‘red’’ chromatin show no significant difference regarding their dosage
compensation states on the neo-X, which is consistent with the lack of H3K36me3 chromatin mark in red chromatin [43], and the dosage
compensation complex targeting genes with such a mark. (D) Expression levels of genes in D. pseudoobscura whose homologs in D. miranda are
bound/unbound by MSL/H4K16ac on the neo-X or bound/unbound by H3K9me2 on the neo-Y; D. pseudoobscura expression levels can be used as a
proxy for ancestral expression of neo-sex linked genes.
doi:10.1371/journal.pbio.1001711.g005
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Figure S7), suggesting that overall patterns of chromatin structure
are conserved between species, and that we can use D. melanogaster
as a proxy for the ancestral chromatin configuration [43]. We
indeed find that genes that are located in active (‘‘yellow’’)
chromatin (Figure S8) are more likely to have evolved MSL-
mediated dosage compensation on the neo-X, while genes in silent
(‘‘black’’) chromatin are more likely to have become heterochro-
matic on the neo-Y (Figure 5B and 5C). A similar pattern is also
found using female D. miranda chromatin states for approximating
the ancestral chromatin configuration of the neo-sex chromosomes
(Figure S9). While the neo-X is no longer autosomal in this
comparison, the chromatin structure (as measured by H4K16ac
enrichment) is similar between the X and autosomes in females
and differs dramatically in males (Figure S10), indicating that D.
miranda females should also provide a good proxy for the ancestral
chromatin structure of the neo-sex chromosomes. Chromatin
states are overall conserved between D. melanogaster and D. miranda
females, validating our inferences of ancestral chromatin states
(Figure S11).
In addition, homologs of H3K9me2-bound genes are expressed
at significantly lower levels in D. pseudoobscura compared to
homologs of neo-Y genes that are not targeted by H3K9me2
(Wilcoxon test: W=746184; p-value,0.01), while genes bound by
MSL and/or H4K16ac on the neo-X tend to have higher
expression levels in D. pseudoobscura than those not targeted by the
dosage compensation machinery (W=846410.5, p-value,2.2e–
16; Figure 5D). This is consistent with heterochromatic regions on
the neo-Y being ancestrally less transcriptionally active, while
dosage compensation on the neo-X preferentially evolved in
transcriptionally active chromosomal segments. Thus, the acqui-
sition of a hyper-transcribed state on the neo-X is accompanied by
the acquisition of an inert, heterochromatic chromatin structure
on the neo-Y, but neither epigenetic modification appears to
directly trigger the other (Figure 6).
Discussion
D. miranda has a unique karyotype, harboring three sex
chromosomes of different ages: XL is the ancestral X chromosome
in the genus Drosophila and .60 MY old, XR became X-linked
about 15 MY ago, is entirely dosage compensated [32] and its
former homolog is completely degenerated (i.e., all genes on
XR are hemizygous in males [44]). This implies that a former
autosome can become completely transformed into a
heteromorphic sex chromosome within only 15 MY in Drosophila.
The much younger neo-sex chromosomes are at an earlier stage of
this evolutionary transition, and the neo-Y is only partially
degenerated and the neo-X has evolved incomplete dosage
compensation. This provides a unique opportunity to study the
evolutionary processes driving the differentiation of sex chromo-
somes, and here we investigate how changes to the DNA sequence
result in novel epigenetic modifications of the diverging neo-sex
chromosomes that affect levels of transcription of neo-sex linked
genes. Recruitment of the dosage compensation complex to the
neo-X requires the acquisition of a 21-bp consensus motif, and we
uncover diverse mutational paths that have led to the evolution of
novel CES on the neo-X. This highlights how evolution can follow
predictable genetic trajectories by repeatedly acquiring the same
21-bp consensus motif for recruitment of the dosage compensation
complex, yet utilizing a diverse array of random mutational
changes to attain the same phenotypic outcome. We further show
that heterochromatin formation is triggered by an accumulation of
repetitive DNA on the neo-Y, and silences adjacent genes.
Surprisingly, we find little correspondence between Y degener-
ation and dosage compensation in D. miranda. Many non-
functional neo-Y genes are not dosage compensated on the neo-
X while many potentially functional neo-Y genes reside within
dosage compensated blocks. Spreading of the MSL-complex
implies that the acquisition of dozens of CES can result in dosage
compensation of hundreds of genes along the neo-X, many with
functional and expressed homologs on the neo-Y. Patterns of gene
expression confirm that many neo-sex genes are either over- or
under-expressed, i.e., there is rampant suboptimal transcription in
male D. miranda. Dosage compensation of functional genes and
transcription of pseudogenes from the neo-Y may in fact select for
adaptive downregulation of those genes from the neo-Y, i.e., the
degeneration of genes on the neo-Y that are dosage compensated
on the neo-X would be selectively favored. Thus, once an evolving
X chromosome acquires dosage compensation mechanisms that
operate through large-scale modifications to its chromatin
structure, such as in Drosophila, the entire evolutionary dynamics
of sex chromosome evolution will change. While Y degeneration at
the initial stages of sex chromosome evolution is a deleterious
process with negative consequences to fitness, degeneration of neo-
Y genes whose homologs are dosage compensated on the neo-X
should restore optimal levels of gene expression, and thus improve
fitness. This will result in complex patterns of Y degeneration over
evolutionary time, and confounds comparisons of sex chromosome
Figure 6. Model of chromatin changes at evolving neo-sex chromosomes. The process of heterochromatin formation of the neo-Y
chromosome appears to be initiated from repressive (black) chromatin regions and dosage compensation on the neo-X preliminary evolves from
active (yellow) chromatin.
doi:10.1371/journal.pbio.1001711.g006
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evolution in taxa with different modes of dosage compensation
[45].
While heterochromatin formation on the neo-Y occurs
simultaneously with dosage compensation on the neo-X in D.
miranda, the genomic regions that are being targeted by MSL-
dependent dosage compensation on the neo-X and heterochro-
matin on the neo-Y show little overlap. This may reflect
different propensities of the ancestral chromosome that formed
the neo-sex chromosome to evolve active versus repressive
chromatin configurations (Figure 6). In particular, the MSL-
complex spreads along the X chromosome by targeting actively
transcribed regions, and spreading should be more efficient in
chromosomal neighborhoods that display higher levels of
genetic activity. In contrast, active transcription suppresses the
spreading of heterochromatin, and heterochromatin is more
likely to form and propagate in genetically inert regions. We
show that chromosomal neighborhoods of the neo-sex chromo-
some with ancestrally higher levels of expression and that are
classified as active chromatin are more likely to be targeted by
the MSL-complex on the neo-X; in contrast, ancestrally silent
chromatin with reduced gene expression is more likely to have
adopted a heterochromatic appearance on the neo-Y. Thus, the
antagonizing effects of active transcription and associated
differences in chromatin structure can help to explain the
evolution of epigenetic modifications on diverging sex chromo-
somes.
The epigenome of sex chromosomes is very different in
mammals compared to Drosophila. For one, the Y chromo-
some in mammals is less heterochromatic than in Drosophila
[46]. The human Y contains one large heterochromatic block
[47], but most genes appear to reside within the euchromatic
part of the chromosome, and the macaque Y chromosome
contains almost no heterochromatin [48]. Also, dosage
compensation works in opposite directions in mammals and
flies, with one of the two X chromosomes being inactivated in
female mammals [35]. X chromosome inactivation (XCI) in
mammals is initiated in early embryogenesis by Xist RNA that
localizes to the inactive X chromosome. Xist induces XCI by
spreading in cis across the future inactive X chromosome [49],
recruiting a polycomb repressive complex [50], and forming a
transcriptionally silent nuclear compartment enriched for
repressive chromatin modifications including H3K27me3
[50]. XCI in mammals is initiated from a single region on
the X (the X inactivation center, the genomic location from
which Xist is being transcribed), while Drosophila contains
hundreds of CES along its X. Both the repressive chromatin
modification in mammals and the active chromatin modifica-
tion in Drosophila spread across the chromosome in a
sequence-independent manner. During initiation of XCI, Xist
transfers to distal regions across the X chromosome by
exploiting the three-dimensional conformation of the X
chromosome; i.e., Xist coats the X chromosome by searching
in three dimensions, modifying chromosome structure, and
spreading to newly accessible locations [51]. The MSL-
complex of Drosophila spreads along the X chromosome by
recognizing features of actively transcribed genes (i.e.,
H3K36me3 modification), but it is not known if MSL spreads
linearly along the X chromosome, or in three dimensions as
well. During the maintenance of XCI in mammals, Xist binds
broadly across the X chromosome [51] while the MSL-
complex in flies is highly enriched in actively transcribed genes
[10]. While we find little correspondence between whether a
gene is dosage compensated on the neo-X and whether its neo-
Y homolog is functional in D. miranda, X inactivation in
humans appears primarily driven by gene loss on the Y, and
X-inactivation status can successfully classify 90% of X-linked
genes into those with functional or nonfunctional Y homologs
[52].
To conclude, our study highlights both the potential and the
limitations of adaptation. On one hand, we show that the neo-X
has rapidly evolved dosage compensation, and makes use of
different mutations to acquire MSL-binding motifs. This illustrates
how evolution can repeatedly attain the same phenotypic
outcome, yet utilizing diverse underlying mutational paths, and
demonstrates how random de novo mutations and natural selection
can quickly respond to fitness costs resulting from gene decay on
the neo-Y by co-opting the existing dosage compensation
machinery. On the other hand, the peculiar mechanistic property
of the MSL-complex to spread along the chromosome results in
suboptimal patterns of dosage compensation on the neo-X,
causing compensation of many functional neo-Y genes. This in
turn sets the stage for adaptive Y-degeneration to restore optimal
expression levels of dosage compensated neo-sex linked genes.
Thus, our study reveals a dynamic interplay between Y
degeneration and dosage compensation, and shows how epigenetic
modifications drive the evolution of silent and hyper-transcribed
chromatin on evolving sex chromosomes, though neither directly
triggers the other.
Materials and Methods
SNP Calling and Neo-Y Annotation
We sequenced single individuals of both sexes from an inbred D.
miranda strain (MSH22) at ,90-fold coverage for each sex. The
genome assembly and annotation has been greatly improved
relative to the earlier version presented in [25] (N50 length:
1,029 kb versus 23.7 kb), because of the increased sequencing
coverage and inclusion of Illumina libraries with different insert
sizes and 454 data [32]. We aligned the genomic reads of male and
female against this improved version of D. miranda chromosome
sequences using bowtie2 [53] using the ‘‘sensitive-local’’ parameter
set and taking the read orientation and library insert size into
consideration, and then screened the alignments by their mapping
qualities (Q.20, where ‘‘Q’’ is the mapping quality determined by
bowtie2 and Q.20 means a certain alignment has less than 1%
chance to be spurious). Following the standard GATK pipeline
[54], PCR duplicate reads were removed and reads were realigned
before calling variants with UnifiedGenotyper. We discarded
SNPs/indels with low qualities (quality,30) or coverage
(depth,5) or showing unusual strand-biases or clustering patterns.
Since we have sequenced single individuals of an inbred D. miranda
strain (three libraries per sex), male-specific variants linked to the
neo-sex chromosomes should likely represent neo-Y specific
mutations. We have identified a total of 380,684 such mutations
(putative neo-Y specific mutations), translating to an average
divergence level of 1.8 sites per 100 bp between the neo-X/Y. We
estimated the false positive discovery rate to be about 2% to 4%,
based on the numbers of male-specific variants on autosomes. The
putative neo-Y specific mutations were introduced into the neo-X
chromosome sequence to build a reference-based neo-Y chromo-
some assembly. There are a total of 169,046 neo-X/Y divergence
sites identified from 2,496 neo-sex linked genes (92.4% of all
annotated genes) with an average of 67 divergent sites per gene.
This provides diagnostic sites dense enough for our further
discrimination between neo-X and neo-Y ChIP-seq/RNA-seq
reads. We then used predicted neo-X protein sequences to
annotate the reconstructed sequence of the neo-Y, and any genes
containing premature stop codons or frameshift mutations were
Evolving Epigenetic Landscape of Sex Chromosomes
PLOS Biology | www.plosbiology.org 9 November 2013 | Volume 11 | Issue 11 | e1001711
characterized as neo-Y genes with disrupted ORFs. We inferred
genes deleted from the neo-Y by comparing the mapping coverage
between sexes (Figure S12) and conditioned on a lack of male-
specific variants in such genes; neo-Y deletion genes are defined as
those showing the same distribution of mapping coverage between
sexes as X-linked genes. Note that most of our analysis of neo-Y
chromosome features is done relative to the neo-X focusing on
these neo-X/Y divergent sites; the few genes/gene regions that
lack diagnostic SNPs between the neo-sex chromosomes should
not greatly bias our analysis (6.6% of all genes).
Evolutionary Analysis
To infer the molecular evolution and conservation of CES, we
used the software package Mercator [55] to generate whole-
genome alignments between D. miranda, D. pseudoobscura, and the
more distant outgroup D. affinis, for comparison along the neo-X,
and D. melanogaster for contrasts of CES on XL. We used FIMO
[56], part of the MEME [57] suite, to identify genomic regions
showing homology to the MRE motif and extracted from the
whole-genome alignment the highest scoring motif within 500 bp
of each CES summit on the neo-X chromosome. We manually
examined each alignment to infer the mutational path by which
the motif arose in D. miranda.
Polytene Chromosome Immunostaining and ChIP-seq
Polytene chromosomes were isolated from male third instar
larvae and processed for immunostaining as described [8].
Chromatin immunoprecipitation from sexed male and female
third instar larvae were prepared as described [8]. The following
antibodies against histone modifications were used for ChIP-seq
experiments: (1) anti-H3K9me2 (Abcam ab1220; 3 ml/IP); (2) anti-
H3K27me3 (Abcam ab6002; 5 ml/IP); (3) anti-H3K36me3
(Abcam ab9050; 3 ml/IP); and (4) anti-H4K16ac (Millipore 07-
329; 5 ml/IP). Immunoprecipitated and input DNAs were purified
and processed according to the standard paired-end Solexa library
preparation protocol. Paired-end 100-bp DNA sequencing was
performed on the Illumina Genome Analyzer located at UC
Berkeley Vincent J. Coates Genomic Sequencing Facility. The
following data sets were used from [32]: (1) anti-H3K36me3 male
third instar larvae; (2) anti-H4K16ac male third instar larvae; (3)
MSL3-TAP mixed-sex larvae, accession numbers SRS402820 and
SRS402821.
ChIP-seq Analysis
We aligned the ChIP-seq and input control reads against the
reference genome using bowtie2 and then separated them into
neo-X or neo-Y linked reads using male-specific variants. Only
reads containing diagnostic variants that allow us to distinguish
between the neo-X and the neo-Y allele are used for this analysis,
and we only kept reads that have a mapping quality of .30 (such
reads have a ,0.001 chance to be misidentified as a result of
misalignment) and we further require each diagnostic site to have
at least three reads for both neo-X and neo-Y alleles to be
considered (see Table S3). Removing regions with no input signal,
Log2 mapping coverage ratio of ChIP versus control was
investigated along the gene body, including 3 kb of up- and
downstream regions, to reflect the binding intensities of certain
chromatin markers. The distributions of binding intensities usually
show a distinctive bimodal pattern on sex or neo-sex chromosomes
compared to autosomes; thus we defined the bound/unbound
genes for each chromatin markers at the values where the two
peaks of distribution separated out (Figure S13). We also extracted
the chromatin state ‘‘color’’ information for all the D. melanogaster
genes from [43]. To associate such information with D. miranda
genes, we used ortholog information between D. pseudoobscura and
D. melanogaster retrieved from FlyBase.
Repeat Analysis
We generated a consensus D. miranda repeat library with
RepeatModeler and RepeatMasker (http://www.repeatmasker.
org), using both the latest D. miranda genome assembly (from
females) [32] and a previous de novo assembly of the neo-Y [25].
We mapped reads from a genomic library of D. miranda males (less
than 1 kb insert size) against neo-sex linked genes and their
flanking regions using bowtie2 with single-end reads mapping
mode, and ‘‘sensitive-local’’ option, and assigned linkage of the
reads to the neo-X/Y according to male-specific diagnostic SNPs
(Figure S14). We then mapped the other mate pair of the neo-X or
neo-Y specific read against the repeat consensus library, to
estimate local repeat density at neo-X versus neo-Y focal genes.
The mapping was done using bowtie2 with single-end reads
mapping mode, and ‘‘very-sensitive-local’’ parameter set.
Gene Expression Analysis
Our genome assembly of the highly repeat-rich neo-Y is not
yet of sufficient quality and contiguity to directly extract genes
from the de novo assembly. Most of our analysis studying the
chromatin structure of the neo-Y, or its genomic composition
(i.e., analysis of the ChIP-seq data, or TE enrichment on the
neo-Y) was done relative to the neo-X. For this analysis,
reconstructing the neo-Y sequences as outlined above by
introducing male-specific variants was appropriate. To study
the transcriptome, we wanted to compare expression levels from
the neo-sex chromosome to their ancestral expression levels in
D. pseudoobscura and contrast expression in males versus females,
to test for an upregulation of dosage compensated neo-X genes,
and downregulation of neo-Y transcripts. For this analysis, we
required absolute expression levels of neo-sex transcripts, to
compare across sexes and species, and we generated de novo
transcriptome assemblies for D. miranda and D. pseudoobscura,
using trinity [58]. The pipeline for the assembly of the neo-sex
transcriptomes will be described in more detail (VBK and DB,
unpublished data); briefly, neo-X transcripts were re-construct-
ed using a trinity transcriptome assembly from females, and
neo-Y transcripts were re-constructed using a trinity transcrip-
tome assembly from males, which was modified to contain all
neo-Y-specific variants; this procedure was necessary to resolve
chimeric neo-X/Y transcripts produced by trinity. In particular,
sections of neo-Y transcripts were kept for the final assembly
only if they contained at least one neo-X/neo-Y distinguishing
variant, and if they were fully supported by RNA-Seq reads; and
genes inferred to be deleted from the neo-Y were excluded from
the neo-Y assembly. The neo-sex transcriptome has been
submitted to GenBank, accession number GALP00000000. To
calculate transcript abundance, neo-X and neo-Y RNA-seq
reads from male and female larvae were mapped against the
neo-sex chromosomal transcripts using Mosaik (http://
bioinformatics.bc.edu/marthlab/wiki/index.php/Software), al-
lowing for zero mismatches, i.e., reads were exclusively assigned
to their respective neo-sex chromosomes of origin, whenever
there was a SNP or indel present. eXpress [59] probabilistically
assigns all reads to alleles (including reads mapping to both the
neo-X and neo-Y) and was used to calculate transcript
abundance (FPKM) for the neo-X in D. miranda, separate from
any neo-Y expression, and vice versa; similarly, eXpress was used
to calculate transcript abundance in D. pseudoobscura. We defined
a neo-Y gene to be actively transcribing if its FPKM value is
higher than 1, which is derived as a cut-off from comparing
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FPKM distributions of genes versus intergenic regions (Figure
S15). FPKM values for each gene are given in Dataset S1.
Accession Numbers
The ChIP-seq data have been deposited in NCBI Short Reads
Archive under the accession number SRR899838, and RNA-seq
data has been deposited under the accession number SRR899847
and SRR899848. The transcriptome shotgun assembly project has
been deposited at DDBJ/EMBL/GenBank under the accession
GALP00000000. The version described in this paper is the first
version, GALP01000000.
Supporting Information
Dataset S1 Expression values (FPKM) for genes on
element C in D. miranda and D. pseudoobscura male
and female larvae, and enrichment levels (log2[ChIP-seq/
input control]) forMSL3, H4K16ac, andH3K36me3 on the
neo-X and H3K9me2 on the neo-Y of D. miranda males.
(XLS)
Figure S1 Male-specific targeting and expression of the
MSL-complex in D. miranda. (A) roX2 RNA-FISH of D.
miranda male salivary glands. We cloned the roX2 gene and
performed RNA-FISH, using a similar protocol as described in
[60]. (B) Male-specific expression of MSL2, roX1, and roX2.
(TIF)
Figure S2 Intensity of MSL-binding versus number of
MRE motifs found at CES. CES with multiple MREs show
significantly more MSL-binding, than CES with single MREs
(one-tailed Wilcoxon test p=0.038).
(TIF)
Figure S3 Dosage compensation and neo-Y degenera-
tion. Genes that are targeted by the MSL complex on the neo-X
are shown in pink, and genes that are not bound by MSL are
shown in grey. (A) The proportion of MSL-bound genes does not
differ between neo-X genes whose neo-Y homologs are potentially
functional (intact neo-Y ORF) versus those whose neo-Y homologs
are non-functional (disrupted neo-Y ORF). Genes that are
transcriptionally silent on the neo-Y are less likely to be dosage
compensated on the neo-X, while actively transcribed neo-Y genes
are more often dosage compensated.
(TIF)
Figure S4 MSL3 enrichment level is significantly corre-
lated with that of H4K16ac. Shown are dot plots of log2 read
depth ratios of ChIP-seq versus input control along the gene body
for MSL3 and H4K16ac chromatin marker on different X
chromosomes, which significantly correlate with each other (R-
square = 0.47–0.49, p-value,2.2e–16).
(TIF)
Figure S5 Pattern of dosage compensated genes that are
defined by MSL binding only. We observe similar patterns as
in Figure 4C and Figure 4D if we define dosage compensated
genes on the neo-X only by significant MSL binding.
(TIF)
Figure S6 No correlation of neo-Y downregulation
versus neo-X dosage compensation. The x-axis shows
reduction of neo-Y expression level measured as the log2 ratio
of neo-Y gene specific FPKM values versus those of D. pseudoobscura
orthologs against the MSL-binding enrichment ratio of their
corresponding neo-X genes.
(TIF)
Figure S7 Gene expression patterns for autosomal
genes in D. miranda, classified by their different
chromatin types defined in D. melanogaster. (A) We find
characteristic D. miranda gene expression patterns of each
chromatin type that is similar to that of D. melanogaster (i.e.,
reduced gene expression in repressive ‘‘black’’ or ‘‘blue’’
chromatin, and higher gene expression in active ‘‘red’’ or
‘‘yellow’’ chromatin). (B) Genes in black and blue chromatin
are more tissue-specific (measured by testis-specificity in D.
miranda), consistent with their patterns of tissue-specific
expression in D. melanogaster. These consistent expression
patterns between species suggest that we can approximate the
D. miranda ancestral chromatin types by their D. melanogaster
orthologs.
(TIF)
Figure S8 Ancestral chromatin states of H4K16ac
bound/unbound genes on chrXR. ChrXR (the Muller D
element) is another young X chromosome that originated around
15 MY ago in an ancestor of D. miranda and D. pseudoobscura, and
has evolved full dosage compensation. Dosage compensated genes
on XR (defined as those bound by H4K16ac chromatin marks) are
enriched for genes within an active chromatin state (‘‘yellow’’
chromatin) in D. melanogaster.
(TIF)
Figure S9 H4K16ac-bound/unbound neo-X genes and
H3K9me2-bound/unbound neo-Y genes versus chroma-
tin states of female D. miranda. We approximate the
ancestral chromatin states by ChIP-seq data of female D. miranda
larvae: blue genes were defined by their characteristic H3K27me3
bound state, green genes by H3K9me2, yellow genes by
H3K36me3 and high expression level (FPKM.2), while black
genes are not bound by any studied histone markers and show a
low expression level (FPKM,2). We grouped the rest of the genes
into an unclassified category as grey genes.
(TIF)
Figure S10 Chromatin structure of sex chromosomes
versus autosomes in males versus females. Chromatin
structure (as measured by H4K16ac enrichment) is similar
between the X and autosomes in females and differs dramatically
on the X and autosomes in males of D. miranda. Each boxplot
shows log2 read depth ratio of ChIP-seq versus input control along
the gene body including the flanking 3 kb regions on a specific
chromosome.
(TIF)
Figure S11 Chromatin states are overall conserved
between D. melanogaster and D. miranda females. We
define chromatin types either in D. melanogaster, using the
classification of [43], or in D. miranda, using the classification
described in Figure S9. The pie charts show the composition of
a particular type of chromatin defined in one species (active
‘‘yellow’’ chromatin on top; inactive ‘‘black’’ [and ‘‘grey’’ for D.
miranda] on the bottom) in the other species. For example, the
upper left pie shows the ‘‘yellow’’ genes defined by D.
melanogaster and their chromatin type compositions defined using
D. miranda female data. Overall, both definitions of active versus
repressive chromatin show a high overlap between species,
suggesting chromatin types of orthologous genes are relatively
conserved.
(TIF)
Figure S12 Identification of deleted genes on the neo-Y
chromosome. (A) Shown is the histogram of male versus female
coverage ratios at exonic regions for all D. miranda genes. A cutoff
Evolving Epigenetic Landscape of Sex Chromosomes
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(dotted line, log2(male/female) =20.5) separating the distribution
of autosomes and X chromosomes was picked to identify genes
that are deleted from the neo-Y chromosome. (B) Metagene plot of
male/female coverage for different classes of genes (X-linked,
autosomal, neo-sex genes with/without deleted neo-Y), across the
gene body.
(TIF)
Figure S13 Definition of bound/unbound genes for
different chromatin marks. Shown is the histogram of
the log2 coverage ratio of ChIP-seq versus input control along
the gene body including up/downstream 3 kb regions
separately for each chromosome. Autosomes are in green,
chrXL in red, chrXR in purple, neo-X in orange, and neo-Y
in blue. Cutoffs discriminating bound/unbound genes were
chosen where the bimodal distribution is separated for two
peaks or sex/neo-sex chromosomes are separated from the
autosomes.
(TIF)
Figure S14 Schematic diagram of repeat enrichment
analyses. To identify neo-Y specific enrichment of repeat
sequences, we counted the ratio of mate-pairs where one read
spanned a neo-X/Y diagnostic SNP and the other read mapped to
a repeat sequence in our consensus repeat library for D. miranda.
(TIF)
Figure S15 Identification of active and silent neo-Y
genes. Shown is the histogram of FPKM values derived from
genes (solid line) and intergenic regions (dotted line). The peak
of the FPKM distribution at intergenic regions is chosen as a
cut-off to determine whether a gene is active or silent on the
neo-Y.
(TIF)
Table S1 MSL-binding and H4K16ac enrichment for
genes on different chromosomes.
(DOCX)
Table S2 GO terms significantly enriched in neo-X
genes that are targeted/not targeted by the dosage
compensation complex.
(DOCX)
Table S3 ChIP-seq reads mapped to neo-X and neo-Y
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